Complex Generics Topical Products Part

FDA discusses topics in

FDA discusses additional topics in

Sam Raney from the Division of Therapeutic Performance in CDER's Office of

Sam Raney, CDER Office of

FDA discusses additional topics in

Kelley Burridge, CDER Office of Pharmaceutical Quality (OPQ), discusses OPQ considerations and how to resolve ANDA ...

Markham C. Luke from CDER's Office of Generic Drugs discusses

Priyanka Ghosh, CDER Office of

Tannaz Ramezanli from the Division of Therapeutic Performance in the Office of

Priyanka Ghosh from the Division of Therapeutic Performance in the Office of

FDA's Director of the Office of

Presenters respond to audience questions. ----------------------------- FDA CDER's Small Business and Industry Assistance (SBIA) ...

Presenters respond to audience questions. ----------------------------- FDA CDER's Small Business and Industry Assistance (SBIA) ...

Eleftheria Tsakalozou, CDER Office of

FDA discusses

Lei Zhang from the Office of

Complex Generics

Presenters Brock Roughton, Tannaz Ramezanli, Priyanka Ghosh, and Sam Raney answer audience questions. Learn more at ...

Darby Kozak from CDER's Office of

Dr. Sally Choe, Director, Office of